R&D channel feed – Endpoints News

R&D channel feed

Merck hands Swedish biotech €10M cash to develop anti-inflammatory drugs

3 years ago

Drug prices 'not justified' by pharma R&D spending, new study says

3 years ago

Biogen CEO says company 'lost its way,' cuts $125M MS partnership amid declining revenue

3 years ago

AlloVir unwraps PhII data of cell therapy in expanded transplant indication, leaves trial plans up in the air

3 years ago

FDA to review Galera’s drug for radiotherapy complication, biotech immediately seeks $30M

3 years ago

Updated: J&J returns rights to early-stage, RNAi NASH candidate to Arrowhead

3 years ago

Cullinan Oncology drops $25M upfront for candidate from Harbour

3 years ago

With a year full of readouts ahead, Disc Medicine secures cash from Bain Capital

3 years ago

FDA hands down RTF letter to rare disease biotech's lead candidate

3 years ago

GSK revises Covid deal with Vir, pulls out of next-gen work

3 years ago

John Reed lands in the top R&D post at J&J in his latest Big Pharma debut

3 years ago

Incyte says under-the-radar JAK inhibitor clears a high bar for skin disorder

3 years ago

Giving first glimpse of data, Scancell looks for Covid-19 vaccine partner

3 years ago

Frequency Therapeutics reports trial fail and lays off over half of staff — stock capsizes

3 years ago

G1 Therapeutics abandons PhIII colorectal cancer trial after disappointing overall response rates

3 years ago

Bristol Myers, 2seventy roll out full Abecma data in earlier-stage cancer

3 years ago

Aristea shutters, ending hopes of a Pfizer buyout

3 years ago

Eliem CEO exits as neuro upstart chops headcount, pivots to preclinical program

3 years ago

Oramed to review strategic alternatives, clouding path forward for oral insulin

3 years ago

FDA advisors vote 8-5 in favor of GSK's Jemperli trial plan for rare rectal cancer

3 years ago

SK Bioscience plans $261M expansion in South Korea with new facility

3 years ago

Updated: AbbVie leaves some oncology programs out of 2023 pipeline highlights

3 years ago

UK microcap faces partial clinical hold in mid-stage IPF trial

3 years ago

AstraZeneca snips IL-12 candidate from pipeline as it sharpens I/O focus

3 years ago

First page Previous page 99 100 101102103 104 105 Next page Last page